| Gene symbol | HLA-B | Synonyms | AS, B-4901, HLAB | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p21.33 | dbXrefs | |
| Description | major histocompatibility complex, class I, B | ||||
| Gene symbol | HLA-G | Synonyms | MHC-G | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p22.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | major histocompatibility complex, class I, G | ||||
| GTO ID | GTC1157 |
| Trial ID | NCT00003646 |
| Disease | Melanoma |
| Altered gene | HLA-B|HLA-G |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | allovectin-7 |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | Phase II Study of Allovectin-7 as an Immunotherapeutic Agent in Patients With Stages III and IV Melanoma |
| Year | 1999 |
| Country | United States |
| Company sponsor | Vical |
| Other ID(s) | CDR0000066735|VCL-1005-205 |
| Cohort 1 | |||||
|
|||||